User profiles for Sadia Ajaz

Sadia Ajaz, PhD.

University of Health Sciences, Lahore-Pakistan.
Verified email at uhs.edu.pk
Cited by 123

Association of a Single-Nucleotide Polymorphism in the Promoter Region of the VEGF Gene with the Risk of Renal Cell Carcinoma

S Ajaz, S Khaliq, A Abid, AS Hassan… - Genetic testing and …, 2011 - liebertpub.com
Aims: Vascular endothelial growth factor (VEGF) protein plays an important role in tumor
development and progression. Polymorphisms in the VEGF gene may lead to over- or …

Analysis of the glutathione S-transferase genes polymorphisms in the risk and prognosis of renal cell carcinomas. Case-control and meta-analysis

A Abid, S Ajaz, AR Khan, F Zehra, AS Hasan… - … Oncology: Seminars and …, 2016 - Elsevier
Background The Glutathione S-transferases (GSTs) genes deletion polymorphisms have
been associated with the progression of several cancers. The association studies between the …

Association of specific single nucleotide variants (SNVs) in the promoter and 3′-Untranslated region of Vascular Endothelial growth factor (VEGF) gene with risk and …

S Ajaz, R Muneer, A Siddiqa, MA Memon, S Firasat… - Oral Oncology, 2021 - Elsevier
Background Head and Neck Cancers (HNCs)comprise one of the most frequent cancers in
South-Asian region. Vascular Endothelial Growth Factor (VEGF) has a potent role in …

Altered gene expression profiles define pathways in colorectal cancer cell lines affected by celecoxib

N Fatima, M Yi, S Ajaz, RM Stephens, S Stauffer… - … Biomarkers & Prevention, 2008 - AACR
It is well established that celecoxib, a selective inhibitor of cyclooxygenase-2 (COX-2) and a
tested chemopreventive agent, has several COX-2–independent activities. In an attempt to …

Unique molecular alteration patterns in von Hippel-Lindau (VHL) gene in a cohort of sporadic renal cell carcinoma patients from Pakistan

S Khaliq, S Ajaz, S Firasat, S Shahid, AS Hasan… - Mutation Research …, 2014 - Elsevier
Background Renal cell carcinoma (RCC) is the most frequent form of kidney cancer in adults.
Somatic mutations that inactivate the von Hippel-Lindau (VHL) gene are the most common …

[HTML][HTML] Germline mutation analysis in sporadic breast cancer cases with clinical correlations

S Ajaz, SZ Zaidi, S Ali, A Siddiqa, MA Memon - Frontiers in genetics, 2022 - frontiersin.org
Demographics for breast cancers vary widely among nations. The frequency of germline
mutations in breast cancers, which reflects the hereditary cases, has not been investigated …

Frequencies of TP53 Germline Variations and Identification of Two Novel 3'UTR Variants in a Series of Head and Neck Cancer Cases

S Ajaz, R Muneer, A Siddiqa, MA Memon - medRxiv, 2021 - medrxiv.org
TP53 is a tumour suppressor gene. Its inactivation plays a significant role in the molecular
pathology of cancers. TP53 germline mutations increase the risk of developing multiple …

Polymorphisms in the methylene tetrahydrofolate reductase gene and their unique combinations are associated with an increased susceptibility to the renal cancers

S Ajaz, S Khaliq, A Hashmi, SAA Naqvi… - Genetic testing and …, 2012 - liebertpub.com
Aims: Two single nucleotide polymorphisms in the methylene tetrahydrofolate reductase (MTHFR)
gene, 677C/T and 1298A/C, encode the thermolabile isoforms of the MTHFR enzyme …

[HTML][HTML] Absence of glutathione S-transferase Theta 1 gene is significantly associated with breast cancer susceptibility in Pakistani population and poor overall …

S Ajaz, SZ Zaidi, SM Ali, A Siddiqa, MA Memon… - Frontiers in …, 2021 - frontiersin.org
Deletion of Glutathione S-Transferase Theta 1 (GSTT1) encoding gene is implicated in
breast cancer susceptibility, clinical outcomes, and survival. Contradictory results have been …

The Prevalence of Pharmacogenomics Variants and Their Clinical Relevance Among the Pakistani Population

AR Khan, SH Shah, S Ajaz, S Firasat… - Evolutionary …, 2022 - journals.sagepub.com
Background: Pharmacogenomics (PGx), forming the basis of precision medicine, has
revolutionized traditional medical practice. Currently, drug responses such as drug efficacy, drug …